Clonal t-cell receptor γ-chain gene rearrangements in differential diagnosis of lymphomatoid papulosis from Skin metastasis of nodal anaplastic large-cell lymphoma

Archives of Dermatology

Volumn 147, Issue 8, 2011, Pages 943-947

  Akilov, Oleg E ^a   Pillai, Raju K ^b   Grandinetti, Lisa M ^a   Kant, Jeffrey A ^b   Geskin, Larisa ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; VINCRISTINE;

ADULT; ARTICLE; CASE REPORT; CLONE; DIFFERENTIAL DIAGNOSIS; DRUG RESPONSE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; INGUINAL LYMPH NODE; LARGE CELL LYMPHOMA; LYMPH NODE; LYMPHOCYTIC INFILTRATION; LYMPHOMATOID PAPULOSIS; MALE; MULTIPLE CYCLE TREATMENT; NODAL ANAPLASTIC LARGE CELL LYMPHOMA; PAPULE; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN METASTASIS; SKIN NODULE;

DIAGNOSIS, DIFFERENTIAL; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMATOID PAPULOSIS; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 80051677317     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.187     Document Type: Article

References (29)

1. + lymphoproliferative disorders. Blood. 2000;95(12):3653-3661.
2. Gascoyne RD, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood. 1999;93(11):3913-3921. (Pubitemid 29249840)
3. ten Berge RL, Oudejans JJ, Ossenkoppele GJ, et al. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination. J Clin Pathol. 2000;53(6):445-450. (Pubitemid 30396466)
4. Wood GS. Analysis of clonality in cutaneous T cell lymphoma and associated diseases. Ann N Y Acad Sci. 2001;941:26-30.
5. Kadin ME. Pathobiology of CD30+ cutaneous T-cell lymphomas. J Cutan Pathol. 2006;33(suppl 1):10-17.
6. Willemze R. Lymphomatoid papulosis. Dermatol Clin. 1985;3(4):735-747. (Pubitemid 16214865)
7. Demierre MF, Goldberg LJ, Kadin ME, Koh HK. Is it lymphoma or lymphomatoid papulosis? J Am Acad Dermatol. 1997;36(5, pt 1):765-772. (Pubitemid 27215365)
8. Wood GS, Crooks CF, Uluer AZ. Lymphomatoid papulosis and associated cutaneous lymphoproliferative disorders exhibit a common clonal origin. J Invest Dermatol. 1995;105(1):51-55.
9. Davis TH, Morton CC, Miller-Cassman R, Balk SP, Kadin ME. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med. 1992;326(17):1115-1122.
10. Kaudewitz P, Herbst H, Anagnostopoulos I, Eckert F, Braun-Falco O, Stein H. Lymphomatoid papulosis followed by large-cell lymphoma: immunophenotypical and genotypical analysis. Br J Dermatol. 1991;124(5):465-469.
11. Fornari A, Piva R, Chiarle R, Novero D, Inghirami G. Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? Hematol Oncol. 2009;27(4):161-170.
12. Harris NL, Swerdlow SH, Jaffe ES. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, eds, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:300-3001.
13. Saggini A, Gulia A, Argenyi Z, et al. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: description of 9 cases. Am J Surg Pathol. 2010;34(8):1168-1175.
14. Cerroni L. Lymphomatoid papulosis, pityriasis lichenoides et varioliformis acuta, and anaplastic large-cell (Ki-1+) lymphoma [comment]. J Am Acad Dermatol. 1997;37(2, pt 1):287. (Pubitemid 27355726)
15. Beljaards RC, Willemze R. The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br J Dermatol. 1992;126(6):596-602.
16. Ralfkiaer E, Stein H, Wantzin GL, Thomsen K, Ralfkiaer N, Mason DY. Lymphomatoid papulosis: characterization of skin infiltrates by monoclonal antibodies. Am J Clin Pathol. 1985;84(5):587-593. (Pubitemid 16235296)
17. Staib G, Sterry W. Use of polymerase chain reaction in the detection of clones in lymphoproliferative diseases of the skin. Recent Results Cancer Res. 1995;139:239-247.
18. Greisser J, Palmedo G, Sander C, et al. Detection of clonal rearrangement of Tcell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders. J Cutan Pathol. 2006;33(11):711-715. (Pubitemid 44704321)
19. Aguilera NS, Chen J, Bijwaard KE, et al. Gene rearrangement and comparative genomic hybridization studies of classic Hodgkin lymphoma expressing T-cell antigens. Arch Pathol Lab Med. 2006;130(12):1772-1779. (Pubitemid 44906952)
20. Steinhoff M, Hummel M, Anagnostopoulos I, et al. Single-cell analysis of CD30+cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin. Blood. 2002;100(2):578-584. (Pubitemid 34761122)
21. Gellrich S, Wernicke M, Wilks A, et al. The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T cells (CD30-negative). J Invest Dermatol. 2004;122(3):859-861. (Pubitemid 38471364)
22. Vonderheid EC, Sajjadian A, Kadin ME. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol. 1996;34(3):470-481. (Pubitemid 26083827)
23. Yazawa N, Kondo S, Kagaya M, Yazawa H, Minamitsuji Y, Jimbow K. Successful treatment of a patient with lymphomatoid papulosis by methotrexate. J Dermatol. 2001;28(7):373-378. (Pubitemid 32738205)
24. Kunishige JH, McDonald H, Alvarez G, Johnson M, Prieto V, Duvic M. Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients. Clin Exp Dermatol. 2009;34(5):576-581.
25. Gniadecki R. Neoplastic stem cells in cutaneous lymphomas: evidence and clinical implications. Arch Dermatol. 2004;140(9):1156-1160. (Pubitemid 39223127)
26. Kempf W, Kutzner H, Cozzio A, et al. MUM1 expression in cutaneous CD30+lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Br J Dermatol. 2008;158(6):1280-1287. (Pubitemid 351692893)
27. Paulli M, Berti E, Boveri E, et al. Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily. Hum Pathol. 1998;29(11):1223-1230. (Pubitemid 28525521)
28. Assaf C, Hirsch B, Wagner F, et al. Differential expression of TRAF1 aids in the distinction of cutaneous CD30-positive lymphoproliferations. J Invest Dermatol. 2007;127(8):1898-1904. (Pubitemid 47075358)
29. Benner MF, Jansen PM, Meijer CJ, Willemze R. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders. Br J Dermatol. 2009;161(1):121-127.